SCHEMBL14747609

SCHEMBL14747609

Cc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(N)cc2)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 14/20 0.74
PTGS1 P23219 7/20 0.73
CYP2C9 P11712 4/20 0.73
PDPK1 O15530 3/20 0.73
HDAC3 O15379 2/20 0.73
HDAC4 P56524 2/20 0.73
HDAC1 Q13547 2/20 0.73
HDAC7 Q8WUI4 2/20 0.73
HDAC2 Q92769 2/20 0.73
HDAC10 Q969S8 2/20 0.73
HDAC11 Q96DB2 2/20 0.73
HDAC8 Q9BY41 2/20 0.73
HDAC6 Q9UBN7 2/20 0.73
HDAC9 Q9UKV0 2/20 0.73
HDAC5 Q9UQL6 2/20 0.73
PTGES O14684 1/20 0.73
CA12 O43570 1/20 0.73
PDE5A O76074 1/20 0.73
ABCB11 O95342 1/20 0.73
MT-CO2 P00403 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5420747 1.00 PTGS2 (0.74) PTGS2PTGS1CYP2C9PDPK1HDAC3
SCHEMBL14958860 0.99 PDPK1 (0.73) PTGS2PTGS1CYP2C9PDPK1HDAC3
SCHEMBL8266070 0.93 PTGS2 (0.80) PTGS2PTGS1CYP2C9PDPK1HDAC3
Celecoxib SCHEMBL4905042 0.91 PTGS2 (0.91) PTGS2PTGS1CYP2C9PDPK1HDAC3
SCHEMBL4587051 0.87 PTGS2 (0.73) PTGS2PTGS1CYP2C9PDPK1HDAC3
SCHEMBL18448102 0.87 PTGS2 (0.72) PTGS2PTGS1CYP2C9PDPK1HDAC3
SCHEMBL8265772 0.87 PTGS2 (0.73) PTGS2PTGS1CYP2C9PDPK1HDAC3
SCHEMBL14747582 0.86 PTGS2 (0.67) PTGS2PTGS1CYP2C9PDPK1HDAC3
SCHEMBL12213580 0.86 PDPK1 (0.73) PTGS2PTGS1CYP2C9PDPK1
SCHEMBL8292452 0.86 PTGS2 (0.86) PTGS2PTGS1CYP2C9PDPK1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE44048-E1 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-YL]benzenesulfonamide for the treatment of inflammation or an inflammation-associated disorder G.D. SEARLE LLC (US) 2013-03-05 US disclosed